AKT1 and neoplasm: AKT3-174aa competes with phosphorylated PDK1 (pyruvate dehydrogenase kinase 1), blocks AKT-thr308 phosphorylation, regulates PI3K/AKT signaling, and inhibits GBM cell proliferation, radiation resistance, and anti-tumor activity in vivo.61